Leading the Prevention or Treatment of Life-Threatening Inflammation in the ICU and Cardiac Surgery using CytoSorb® Blood Purification
CytoSorb®, is E.U. approved, with 46,000+ treatments; distributed in 53 countries
Organ failure occurs when vital organs stop working, causing nearly half of all deaths in the ICU.
CytoSorb® targets the $20+ billion opportunity in critical care and cardiac surgery
Approved in the European Union as the first specifically approved extracorporeal cytokine adsorber
Benefits Of CytoSorbents